| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7d8053b1e288eeaa108a0272e0b963c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe5608f5bb23f918fee158b21acdb014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2203f4f4f74aade154084e65d8b1c479
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0bc0517b9816c61760b6685c5c8f227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53966c9f6eb13630e685ffae8b0cc8c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2209-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-009 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-02 |
| filingDate |
2012-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4af99650477914b76e66ec94eb0886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c678fa33bcdc9717728ecd010b67f34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9631cc40122ea4bad81c646d2509d81b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd146107e3850e9fe7ef4d7c5b4d2309 |
| publicationDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8591954-B2 |
| titleOfInvention |
Phospholipid-based inhalation system |
| abstract |
The present invention includes a method for delivering medications deeper into the lungs and to the medications' pulmonary targets, which include bronchioles and alveoli. A first particularly preferred embodiment of the invention describes the use of two steps for delivery of a medication. In a first step, an aerosolized therapeutic composition or medication is administered into a patient's respiratory tract, wherein the patient may be any animal or human subject. Following the first step, an aerosolized surfactant is administered into the patient's respiratory tract that facilitates delivery of the aerosolized medication of the first step to the medication's pulmonary target. Another embodiment of the present invention contemplates an apparatus for the delivery of an aerosolized surfactant used that facilitates delivery of previously inhaled aerosolized medication. |
| priorityDate |
2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |